Jak 2 Mutation

JAK2 Mutation

What it is

The JAK2 Mutation test detects changes in the JAK2 (Janus kinase 2) gene, most commonly the JAK2 V617F mutation. This gene helps regulate blood cell production in the bone marrow. Mutations in JAK2 are linked to myeloproliferative neoplasms (MPNs), a group of blood disorders where the bone marrow makes too many red blood cells, white blood cells, or platelets.

Uses

This test is used to diagnose and classify myeloproliferative disorders such as polycythemia vera, essential thrombocythemia, and primary myelofibrosis. It also helps distinguish these conditions from other causes of abnormal blood counts. In some cases, it is used to monitor disease progression or response to targeted therapies.

Symptoms That May Lead to the Test

Doctors may recommend this test if you have persistently high red blood cell counts, high platelets, or unexplained abnormal white blood cell counts. Symptoms that may prompt testing include headaches, dizziness, fatigue, night sweats, itching, enlarged spleen, frequent blood clots, or unusual bleeding.

Abnormal Results

Positive for JAK2 Mutation: Strongly suggests a myeloproliferative neoplasm such as polycythemia vera, essential thrombocythemia, or myelofibrosis. Further testing may be required to determine the specific condition and treatment approach.

Negative Result: Suggests no JAK2 mutation detected. However, other gene mutations (such as CALR or MPL) may still cause myeloproliferative disorders, so additional genetic testing may be considered if suspicion remains high.

Risks

The test involves a routine blood draw, which carries minimal risks such as slight pain, bruising, or dizziness at the puncture site. In some cases, bone marrow testing may also be recommended, which has additional minor risks.